Research Article
Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease
Table 7
Multivariate analysis of risk factors that hinder improvement in platelet count.
| | Comparison | Odds ratio (95%C.I) | value |
| Baseline total bilirubin (mg/dl) | Per increase in the level | 5.93 (1.15-30.50) | ≤0.033 | Baseline albumin (g/dl) | Per decrease in the level | 0.50 (0.17-1.48) | ≤0.213 | Spleen size (cm) | Per cm increase | 1.55 (1.21-1.98) | ≤0.001 | Portal vein diameter (mm) | Per mm increase | 1.1 (0.82-1.98) | ≤0.523 | Stages of fibrosis: | | | | (i) Mild to moderate | Per increase in stage | 8.67 (0.96-77.96) | ≤0.05 | (ii) Advanced fibrosis and cirrhosis | | |
|
|